Trials / Completed
CompletedNCT00177086
Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral Calculi
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 76 (actual)
- Sponsor
- University of Minnesota · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will assess improvement in the percentage of spontaneous stone passage for distal ureteral calculi for alfuzosin compared to placebo, decrease of pain and narcotic/analgesic use associated with stone passage, decrease of the time to spontaneous stone passage, shift in the size distribution of stones passed towards larger sizes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Alfuzosin Hydrochloride | One tablet every day for 4 weeks |
Timeline
- Start date
- 2005-09-01
- Primary completion
- 2008-01-01
- Completion
- 2008-01-01
- First posted
- 2005-09-15
- Last updated
- 2013-03-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00177086. Inclusion in this directory is not an endorsement.